U.S. Markets closed

Catalent, Inc. (CTLT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
109.14+3.15 (+2.97%)
At close: 04:03PM EDT
109.20 +0.06 (+0.05%)
After hours: 04:34PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close105.99
Bid109.05 x 1000
Ask109.07 x 1000
Day's Range106.40 - 109.40
52 Week Range86.34 - 142.64
Avg. Volume1,269,540
Market Cap18.683B
Beta (5Y Monthly)1.38
PE Ratio (TTM)34.35
EPS (TTM)3.18
Earnings DateJan 31, 2022 - Feb 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est138.15
  • Business Wire

    Catalent Announces New Operating Structure

    SOMERSET, N.J., July 05, 2022--Catalent, Inc. (NYSE: CTLT), the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced changes to its operating structure and executive leadership team that went into effect July 1. This new organizational structure includes a shift from four reporting segments to two, each representing roughly half of the total company revenu

  • Zacks

    Catalent (CTLT) Expands Packaging Capabilities at Japan Facility

    Catalent's (CTLT) latest capability expansion is expected to boost its business in this key hub in its Asia-Pacific Clinical Supply Services network.

  • Zacks

    3 Reasons to Retain Catalent (CTLT) Stock in Your Portfolio

    Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.